메뉴 건너뛰기




Volumn 36, Issue 12, 2017, Pages 2859-2867

Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review

Author keywords

Antiphospholipid syndrome; Eculizumab; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT; CREATININE; CYCLOPHOSPHAMIDE; ECULIZUMAB; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PREDNISONE; CFHR1 PROTEIN, HUMAN; CFHR3 PROTEIN, HUMAN; COMPLEMENT FACTOR I; MONOCLONAL ANTIBODY; PLASMA PROTEIN;

EID: 85029439527     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-017-3823-2     Document Type: Review
Times cited : (40)

References (47)
  • 1
    • 0028376072 scopus 로고
    • Renal vascular complications of systemic lupus erythematosus
    • COI: 1:STN:280:DyaK2c3pslWmtg%3D%3D, PID: 8025223
    • Appel GB, Pirani CL, D'Agati V (1994) Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 4(8):1499–1515
    • (1994) J Am Soc Nephrol , vol.4 , Issue.8 , pp. 1499-1515
    • Appel, G.B.1    Pirani, C.L.2    D'Agati, V.3
  • 2
    • 0025989985 scopus 로고
    • Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL)
    • COI: 1:STN:280:DyaK3MzivVWhsA%3D%3D, PID: 1867181
    • Banfi G, Bertani T, Boeri V et al (1991) Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis 18(2):240–248
    • (1991) Am J Kidney Dis , vol.18 , Issue.2 , pp. 240-248
    • Banfi, G.1    Bertani, T.2    Boeri, V.3
  • 3
    • 0021986361 scopus 로고
    • Incidence and significance of intrarenal vasculopathies in patients with systemic lupus erythematosus
    • COI: 1:STN:280:DyaL2M7ivFWitw%3D%3D, PID: 3972386
    • Tsumagari T, Fukumoto S, Kinjo M, Tanaka K (1985) Incidence and significance of intrarenal vasculopathies in patients with systemic lupus erythematosus. Hum Pathol 16(1):43–49
    • (1985) Hum Pathol , vol.16 , Issue.1 , pp. 43-49
    • Tsumagari, T.1    Fukumoto, S.2    Kinjo, M.3    Tanaka, K.4
  • 4
    • 78649643417 scopus 로고    scopus 로고
    • Clinical characteristics and prognosis of diffuse proliferative lupus nephritis with thrombotic microangiopathy
    • COI: 1:CAS:528:DC%2BC3MXlslartQ%3D%3D, PID: 20798137
    • Hu WX, Liu ZZ, Chen HP, Zhang HT, Li LS, Liu ZH (2010) Clinical characteristics and prognosis of diffuse proliferative lupus nephritis with thrombotic microangiopathy. Lupus 19(14):1591–1598
    • (2010) Lupus , vol.19 , Issue.14 , pp. 1591-1598
    • Hu, W.X.1    Liu, Z.Z.2    Chen, H.P.3    Zhang, H.T.4    Li, L.S.5    Liu, Z.H.6
  • 5
    • 84940363650 scopus 로고    scopus 로고
    • Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications
    • PID: 24382968
    • Vieregge GB, Harrington TJ, Andrews DM, Carpintero MF, Green DF, Nayer A (2013) Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications. Case Rep Med 2013:915309
    • (2013) Case Rep Med , vol.2013 , pp. 915309
    • Vieregge, G.B.1    Harrington, T.J.2    Andrews, D.M.3    Carpintero, M.F.4    Green, D.F.5    Nayer, A.6
  • 6
    • 84896544929 scopus 로고    scopus 로고
    • 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends
    • COI: 1:CAS:528:DC%2BC2cXis1CrtLc%3D, PID: 24468415
    • Erkan D, Aguiar CL, Andrade D et al (2014) 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev 13(6):685–696
    • (2014) Autoimmun Rev , vol.13 , Issue.6 , pp. 685-696
    • Erkan, D.1    Aguiar, C.L.2    Andrade, D.3
  • 7
    • 84921888665 scopus 로고    scopus 로고
    • Catastrophic APS in the context of other thrombotic microangiopathies
    • PID: 25604575
    • Rodriguez-Pinto I, Espinosa G, Cervera R (2015) Catastrophic APS in the context of other thrombotic microangiopathies. Curr Rheumatol Rep 17(1):482
    • (2015) Curr Rheumatol Rep , vol.17 , Issue.1 , pp. 482
    • Rodriguez-Pinto, I.1    Espinosa, G.2    Cervera, R.3
  • 8
    • 84936987706 scopus 로고    scopus 로고
    • 36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature
    • PID: 25389502
    • Strakhan M, Hurtado-Sbordoni M, Galeas N, Bakirhan K, Alexis K, Elrafei T (2014) 36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature. Case Rep Hematol 2014:704371
    • (2014) Case Rep Hematol , vol.2014 , pp. 704371
    • Strakhan, M.1    Hurtado-Sbordoni, M.2    Galeas, N.3    Bakirhan, K.4    Alexis, K.5    Elrafei, T.6
  • 9
    • 84895064562 scopus 로고    scopus 로고
    • Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation
    • COI: 1:CAS:528:DC%2BC2cXhs1eqsbc%3D, PID: 24400968
    • Lonze BE, Zachary AA, Magro CM et al (2014) Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation. Am J Transplant 14(2):459–465
    • (2014) Am J Transplant , vol.14 , Issue.2 , pp. 459-465
    • Lonze, B.E.1    Zachary, A.A.2    Magro, C.M.3
  • 10
    • 0028567103 scopus 로고
    • Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus
    • COI: 1:STN:280:DyaK2M3gslOkuw%3D%3D, PID: 7899874
    • Nesher G, Hanna VE, Moore TL, Hersh M, Osborn TG (1994) Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 24(3):165–172
    • (1994) Semin Arthritis Rheum , vol.24 , Issue.3 , pp. 165-172
    • Nesher, G.1    Hanna, V.E.2    Moore, T.L.3    Hersh, M.4    Osborn, T.G.5
  • 11
    • 84969872350 scopus 로고    scopus 로고
    • Plasmapheresis is associated with better renal outcomes in lupus nephritis patients with thrombotic microangiopathy: a case series study
    • COI: 1:CAS:528:DC%2BC28Xns1aksr0%3D
    • Li QY, Yu F, Zhou FD, Zhao MH (2016) Plasmapheresis is associated with better renal outcomes in lupus nephritis patients with thrombotic microangiopathy: a case series study. Medicine (Baltimore) 95(18):e3595
    • (2016) Medicine (Baltimore) , vol.95 , Issue.18
    • Li, Q.Y.1    Yu, F.2    Zhou, F.D.3    Zhao, M.H.4
  • 12
    • 84884971310 scopus 로고    scopus 로고
    • Eculizumab in atypical hemolytic-uremic syndrome
    • COI: 1:CAS:528:DC%2BC3sXhsF2ksbrN, PID: 24088105
    • Legendre CM, Licht C, Loirat C (2013) Eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 369(14):1379–1380
    • (2013) N Engl J Med , vol.369 , Issue.14 , pp. 1379-1380
    • Legendre, C.M.1    Licht, C.2    Loirat, C.3
  • 13
    • 84857190406 scopus 로고    scopus 로고
    • Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation
    • COI: 1:CAS:528:DC%2BC3MXhsFCmtLvM, PID: 21831149
    • Hadaya K, Ferrari-Lacraz S, Fumeaux D et al (2011) Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation. Am J Transplant 11(11):2523–2527
    • (2011) Am J Transplant , vol.11 , Issue.11 , pp. 2523-2527
    • Hadaya, K.1    Ferrari-Lacraz, S.2    Fumeaux, D.3
  • 14
    • 84864485595 scopus 로고    scopus 로고
    • Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab
    • COI: 1:CAS:528:DC%2BC38XhtV2gtLfN, PID: 22354668
    • Shapira I, Andrade D, Allen SL, Salmon JE (2012) Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab. Arthritis Rheum 64(8):2719–2723
    • (2012) Arthritis Rheum , vol.64 , Issue.8 , pp. 2719-2723
    • Shapira, I.1    Andrade, D.2    Allen, S.L.3    Salmon, J.E.4
  • 15
    • 84881372189 scopus 로고    scopus 로고
    • Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes
    • COI: 1:CAS:528:DC%2BC3sXhsVersb%2FO, PID: 23763583
    • Canaud G, Kamar N, Anglicheau D et al (2013) Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes. Am J Transplant 13(8):2179–2185
    • (2013) Am J Transplant , vol.13 , Issue.8 , pp. 2179-2185
    • Canaud, G.1    Kamar, N.2    Anglicheau, D.3
  • 16
    • 84917728306 scopus 로고    scopus 로고
    • Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report
    • COI: 1:CAS:528:DC%2BC2cXitVKrsbnL
    • Kronbichler A, Frank R, Kirschfink M et al (2014) Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report. Medicine (Baltimore) 93(26):e143
    • (2014) Medicine (Baltimore) , vol.93 , Issue.26
    • Kronbichler, A.1    Frank, R.2    Kirschfink, M.3
  • 17
    • 84920942686 scopus 로고    scopus 로고
    • Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy
    • PID: 25173358
    • Coppo R, Peruzzi L, Amore A et al (2015) Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy. Pediatr Nephrol 30(1):167–172
    • (2015) Pediatr Nephrol , vol.30 , Issue.1 , pp. 167-172
    • Coppo, R.1    Peruzzi, L.2    Amore, A.3
  • 18
    • 84905733420 scopus 로고    scopus 로고
    • A case of thrombotic microangiopathy associated with antiphospholipid antibody syndrome successfully treated with eculizumab
    • PID: 25089339
    • Bakhtar O, Thajudeen B, Braunhut BL et al (2014) A case of thrombotic microangiopathy associated with antiphospholipid antibody syndrome successfully treated with eculizumab. Transplantation 98(3):e17–e18
    • (2014) Transplantation , vol.98 , Issue.3 , pp. e17-e18
    • Bakhtar, O.1    Thajudeen, B.2    Braunhut, B.L.3
  • 19
    • 84940905884 scopus 로고    scopus 로고
    • Eculizumab induces sustained remission in a patient with refractory primary catastrophic antiphospholipid syndrome
    • PID: 26267719
    • Zikos TA, Sokolove J, Ahuja N, Berube C (2015) Eculizumab induces sustained remission in a patient with refractory primary catastrophic antiphospholipid syndrome. J Clin Rheumatol 21(6):311–313
    • (2015) J Clin Rheumatol , vol.21 , Issue.6 , pp. 311-313
    • Zikos, T.A.1    Sokolove, J.2    Ahuja, N.3    Berube, C.4
  • 20
    • 84961960857 scopus 로고    scopus 로고
    • A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor
    • Wig S, Chan M, Thachil J, Bruce I, Barnes T (2016) A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor. Rheumatology (Oxford) 55(2):382–384
    • (2016) Rheumatology (Oxford) , vol.55 , Issue.2 , pp. 382-384
    • Wig, S.1    Chan, M.2    Thachil, J.3    Bruce, I.4    Barnes, T.5
  • 21
    • 84922373286 scopus 로고    scopus 로고
    • Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab
    • COI: 1:CAS:528:DC%2BC2cXhvFarsLnI, PID: 25446020
    • El-Husseini A, Hannan S, Awad A, Jennings S, Cornea V, Sawaya BP (2015) Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab. Am J Kidney Dis 65(1):127–130
    • (2015) Am J Kidney Dis , vol.65 , Issue.1 , pp. 127-130
    • El-Husseini, A.1    Hannan, S.2    Awad, A.3    Jennings, S.4    Cornea, V.5    Sawaya, B.P.6
  • 22
    • 84983094382 scopus 로고    scopus 로고
    • Eculizumab as rescue therapy in severe resistant lupus nephritis
    • Pickering MC, Ismajli M, Condon MB et al (2015) Eculizumab as rescue therapy in severe resistant lupus nephritis. Rheumatology (Oxford) 54(12):2286–2288
    • (2015) Rheumatology (Oxford) , vol.54 , Issue.12 , pp. 2286-2288
    • Pickering, M.C.1    Ismajli, M.2    Condon, M.B.3
  • 23
    • 84990829817 scopus 로고    scopus 로고
    • Atypical hemolytic uremic syndrome secondary to lupus nephritis, responsive to eculizumab
    • PID: 27781079
    • Raufi AG, Scott S, Darwish O et al (2016) Atypical hemolytic uremic syndrome secondary to lupus nephritis, responsive to eculizumab. Hematol Rep 8(3):6625
    • (2016) Hematol Rep , vol.8 , Issue.3 , pp. 6625
    • Raufi, A.G.1    Scott, S.2    Darwish, O.3
  • 24
    • 84986207697 scopus 로고    scopus 로고
    • Use of eculizumab in atypical hemolytic uremic syndrome, complicating systemic lupus erythematosus
    • PID: 27556240
    • Bermea RS, Sharma N, Cohen K, Liarski VM (2016) Use of eculizumab in atypical hemolytic uremic syndrome, complicating systemic lupus erythematosus. J Clin Rheumatol 22(6):320–323
    • (2016) J Clin Rheumatol , vol.22 , Issue.6 , pp. 320-323
    • Bermea, R.S.1    Sharma, N.2    Cohen, K.3    Liarski, V.M.4
  • 25
    • 85017435720 scopus 로고    scopus 로고
    • Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome
    • Geethakumari PR, Mille P, Gulati R, Nagalla S. (2017) Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome. Transfus Apher Sci 56(3):400–403
    • (2017) Transfus Apher Sci , vol.56 , Issue.3 , pp. 400-403
    • Geethakumari, P.R.1    Mille, P.2    Gulati, R.3    Nagalla, S.4
  • 26
    • 0025773511 scopus 로고
    • Significance of anti-phospholipid antibodies in patients with lupus nephritis
    • COI: 1:STN:280:DyaK3MznsV2ktw%3D%3D, PID: 1716712
    • Frampton G, Hicks J, Cameron JS (1991) Significance of anti-phospholipid antibodies in patients with lupus nephritis. Kidney Int 39(6):1225–1231
    • (1991) Kidney Int , vol.39 , Issue.6 , pp. 1225-1231
    • Frampton, G.1    Hicks, J.2    Cameron, J.S.3
  • 27
    • 34548416651 scopus 로고    scopus 로고
    • Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies
    • Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P (2007) Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies. Nephrology (Carlton) 12(5):474–480
    • (2007) Nephrology (Carlton) , vol.12 , Issue.5 , pp. 474-480
    • Cheunsuchon, B.1    Rungkaew, P.2    Chawanasuntorapoj, R.3    Pattaragarn, A.4    Parichatikanond, P.5
  • 28
    • 2442701758 scopus 로고    scopus 로고
    • Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies
    • COI: 1:STN:280:DC%2BD2c3ktFKgug%3D%3D, PID: 15140782
    • Espinosa G, Bucciarelli S, Cervera R et al (2004) Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 63(6):730–736
    • (2004) Ann Rheum Dis , vol.63 , Issue.6 , pp. 730-736
    • Espinosa, G.1    Bucciarelli, S.2    Cervera, R.3
  • 29
    • 4043055247 scopus 로고    scopus 로고
    • Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome
    • PID: 15334471
    • Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM (2004) Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 50(8):2569–2579
    • (2004) Arthritis Rheum , vol.50 , Issue.8 , pp. 2569-2579
    • Tektonidou, M.G.1    Sotsiou, F.2    Nakopoulou, L.3    Vlachoyiannopoulos, P.G.4    Moutsopoulos, H.M.5
  • 30
    • 84939541475 scopus 로고    scopus 로고
    • Thrombotic microangiopathy and poor renal outcome in lupus patients with or without antiphospholipid syndrome
    • PID: 26203932
    • Hernandez-Molina G, Garcia-Trejo LP, Uribe N, Cabral AR (2015) Thrombotic microangiopathy and poor renal outcome in lupus patients with or without antiphospholipid syndrome. Clin Exp Rheumatol 33(4):503–508
    • (2015) Clin Exp Rheumatol , vol.33 , Issue.4 , pp. 503-508
    • Hernandez-Molina, G.1    Garcia-Trejo, L.P.2    Uribe, N.3    Cabral, A.R.4
  • 31
    • 0034650431 scopus 로고    scopus 로고
    • Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B
    • COI: 1:CAS:528:DC%2BD3cXlt1CmtA%3D%3D, PID: 10623824
    • Watanabe H, Garnier G, Circolo A et al (2000) Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol 164(2):786–794
    • (2000) J Immunol , vol.164 , Issue.2 , pp. 786-794
    • Watanabe, H.1    Garnier, G.2    Circolo, A.3
  • 32
    • 0035793334 scopus 로고    scopus 로고
    • Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin
    • COI: 1:CAS:528:DC%2BD3MXhtVaisrc%3D, PID: 11157679
    • Pierangeli SS, Espinola RG, Liu X, Harris EN (2001) Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res 88(2):245–250
    • (2001) Circ Res , vol.88 , Issue.2 , pp. 245-250
    • Pierangeli, S.S.1    Espinola, R.G.2    Liu, X.3    Harris, E.N.4
  • 33
    • 0036137594 scopus 로고    scopus 로고
    • Antiphospholipid syndrome nephropathy in systemic lupus erythematosus
    • PID: 11752020
    • Daugas E, Nochy D, Huong DL et al (2002) Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 13(1):42–52
    • (2002) J Am Soc Nephrol , vol.13 , Issue.1 , pp. 42-52
    • Daugas, E.1    Nochy, D.2    Huong, D.L.3
  • 34
    • 0032979820 scopus 로고    scopus 로고
    • The intrarenal vascular lesions associated with primary antiphospholipid syndrome
    • COI: 1:STN:280:DyaK1M7ntFKjuw%3D%3D, PID: 10073601
    • Nochy D, Daugas E, Droz D et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10(3):507–518
    • (1999) J Am Soc Nephrol , vol.10 , Issue.3 , pp. 507-518
    • Nochy, D.1    Daugas, E.2    Droz, D.3
  • 35
    • 84899104450 scopus 로고    scopus 로고
    • Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients
    • COI: 1:CAS:528:DC%2BC2cXmvVyrs7k%3D
    • Jordan N, Chaib A, Sangle S et al (2014) Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients. Arthritis Care Res (Hoboken) 66(5):725–731
    • (2014) Arthritis Care Res (Hoboken) , vol.66 , Issue.5 , pp. 725-731
    • Jordan, N.1    Chaib, A.2    Sangle, S.3
  • 36
    • 84897051550 scopus 로고    scopus 로고
    • Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study
    • COI: 1:CAS:528:DC%2BC3sXhsl2jsbvI, PID: 24232504
    • Erre GL, Bosincu L, Faedda R et al (2014) Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study. Rheumatol Int 34(4):535–541
    • (2014) Rheumatol Int , vol.34 , Issue.4 , pp. 535-541
    • Erre, G.L.1    Bosincu, L.2    Faedda, R.3
  • 37
    • 84872140900 scopus 로고    scopus 로고
    • The spectrum of renal thrombotic microangiopathy in lupus nephritis
    • COI: 1:CAS:528:DC%2BC3sXnvFaiu7Y%3D, PID: 23320601
    • Song D, Wu LH, Wang FM et al (2013) The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 15(1):R12
    • (2013) Arthritis Res Ther , vol.15 , Issue.1 , pp. R12
    • Song, D.1    Wu, L.H.2    Wang, F.M.3
  • 38
    • 0037700599 scopus 로고    scopus 로고
    • Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells
    • COI: 1:CAS:528:DC%2BD3sXmsl2qt7Y%3D, PID: 12892395
    • Pierangeli SS, Harris EN (2003) Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Lupus 12(7):539–545
    • (2003) Lupus , vol.12 , Issue.7 , pp. 539-545
    • Pierangeli, S.S.1    Harris, E.N.2
  • 39
    • 79953321819 scopus 로고    scopus 로고
    • Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions
    • COI: 1:STN:280:DC%2BC3M7nvVWqsw%3D%3D, PID: 21303833
    • Cervera R, Tektonidou MG, Espinosa G et al (2011) Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus 20(2):165–173
    • (2011) Lupus , vol.20 , Issue.2 , pp. 165-173
    • Cervera, R.1    Tektonidou, M.G.2    Espinosa, G.3
  • 40
    • 49449092487 scopus 로고    scopus 로고
    • Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis
    • PID: 18668574
    • Cohen D, Koopmans M, Kremer Hovinga IC et al (2008) Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum 58(8):2460–2469
    • (2008) Arthritis Rheum , vol.58 , Issue.8 , pp. 2460-2469
    • Cohen, D.1    Koopmans, M.2    Kremer Hovinga, I.C.3
  • 41
    • 84855765646 scopus 로고    scopus 로고
    • Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus
    • PID: 22171659
    • Jonsen A, Nilsson SC, Ahlqvist E et al (2011) Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus. Arthritis Res Ther 13(6):R206
    • (2011) Arthritis Res Ther , vol.13 , Issue.6 , pp. R206
    • Jonsen, A.1    Nilsson, S.C.2    Ahlqvist, E.3
  • 42
    • 85017040990 scopus 로고    scopus 로고
    • High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies
    • COI: 1:CAS:528:DC%2BC28XitFSjtLzO, PID: 26283675
    • Bu F, Borsa NG, Jones MB et al (2016) High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies. J Am Soc Nephrol 27(4):1245–1253
    • (2016) J Am Soc Nephrol , vol.27 , Issue.4 , pp. 1245-1253
    • Bu, F.1    Borsa, N.G.2    Jones, M.B.3
  • 43
    • 84878589219 scopus 로고    scopus 로고
    • Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome
    • COI: 1:CAS:528:DC%2BC3sXpt1Oqu7k%3D, PID: 23738544
    • Legendre CM, Licht C, Muus P et al (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368(23):2169–2181
    • (2013) N Engl J Med , vol.368 , Issue.23 , pp. 2169-2181
    • Legendre, C.M.1    Licht, C.2    Muus, P.3
  • 44
    • 84992309323 scopus 로고    scopus 로고
    • Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
    • PID: 27110144
    • Palma LM, Langman CB (2016) Critical appraisal of eculizumab for atypical hemolytic uremic syndrome. J Blood Med 7:39–72
    • (2016) J Blood Med , vol.7 , pp. 39-72
    • Palma, L.M.1    Langman, C.B.2
  • 45
    • 77951853702 scopus 로고    scopus 로고
    • Eculizumab and renal transplantation in a patient with CAPS
    • COI: 1:CAS:528:DC%2BC3cXls1yksbg%3D, PID: 20445191
    • Lonze BE, Singer AL, Montgomery RA (2010) Eculizumab and renal transplantation in a patient with CAPS. N Engl J Med 362(18):1744–1745
    • (2010) N Engl J Med , vol.362 , Issue.18 , pp. 1744-1745
    • Lonze, B.E.1    Singer, A.L.2    Montgomery, R.A.3
  • 46
    • 0035021077 scopus 로고    scopus 로고
    • Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis
    • COI: 1:STN:280:DC%2BD3M3psF2qug%3D%3D, PID: 11380817
    • Najafi CC, Korbet SM, Lewis EJ et al (2001) Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59(6):2156–2163
    • (2001) Kidney Int , vol.59 , Issue.6 , pp. 2156-2163
    • Najafi, C.C.1    Korbet, S.M.2    Lewis, E.J.3
  • 47
    • 84929128976 scopus 로고    scopus 로고
    • Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies
    • COI: 1:CAS:528:DC%2BC2MXotVCisLY%3D, PID: 25651368
    • Licht C, Greenbaum LA, Muus P et al (2015) Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies. Kidney Int 87(5):1061–1073
    • (2015) Kidney Int , vol.87 , Issue.5 , pp. 1061-1073
    • Licht, C.1    Greenbaum, L.A.2    Muus, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.